As Cell and Gene Therapy (CGT) products transition from the laboratory to the clinic, the design of the clinical trial protocol is not only the starting point for scientific exploration but also the c...
When an innovative therapy aiming for a "one-time cure" is still evaluated by traditional standards that measure "months of survival," its failure may have been predetermined. In 2...
——From AI-driven drug discovery to quantum computing, technology is redefining every aspect of medicine.Generative AI for Drug DiscoveryGenerative AI acts as a super-powered research assistant, simu...
Recent Complete Response Letters (CRL) issued to Replimune and Capricor have made the FDA’s new and intensified scrutiny of clinical trial design clear. As the agency demands greater rigor and ...
Source: 21st Century Health (original reporting) The warmth spreading through China’s pharma space is now radiating downstream to the entire outsourcing chain. WuXi AppTec now expects 2025 top-line ...
After a multi-day winning streak, the CRO concept index hit a fresh high on 25 Jul. Porton (300363.SZ), Pharmaron (3759.HK) and Tigermed (300347.SZ) surged more than 5 %, with dozens of peers ...
